Number of the records: 1  

5-Substituted 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidines with anti-proliferative activity as potent and selective inhibitors of cyclin-dependent kinases

  1. 1.
    0459351 - ÚEB 2017 RIV FR eng J - Journal Article
    Vymětalová, Ladislava - Havlíček, Libor - Šturc, Antonín - Skrášková, Zuzana - Jorda, Radek - Pospíšil, Tomáš - Strnad, Miroslav - Kryštof, Vladimír
    5-Substituted 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidines with anti-proliferative activity as potent and selective inhibitors of cyclin-dependent kinases.
    European Journal of Medicinal Chemistry. Roč. 110, MAR 3 (2016), s. 291-301. ISSN 0223-5234. E-ISSN 1768-3254
    R&D Projects: GA MŠMT(CZ) LO1204; GA ČR(CZ) GA15-15264S
    Institutional support: RVO:61389030
    Keywords : Cyclin-dependent kinase * Inhibitor * Selectivity
    Subject RIV: EB - Genetics ; Molecular Biology
    Impact factor: 4.519, year: 2016

    A series of 5-substituted 3-isopropyl-7-[4-(2-pyridyl)benzyl]amino-1(2)H-pyrazolo[4,3-d]pyrimidine derivatives was synthesized and evaluated for their cyclin-dependent kinase (CDK) inhibition activity. The most potent compounds contained various hydroxyalkylamines at the 5 position and possessed low nanomolar IC50 values for CDK2 and CDK5. Preliminary profiling of one of the most active compounds on a panel of 50 protein kinases revealed its high selectivity for CDKs. The compounds arrested cells in S and G2/M phases, and induced apoptosis in various cancer cell lines. Significant dephosphorylation of the C-terminus of RNA polymerase II and focal adhesion kinase (FAK), well-established substrates of CDKs, has been found in treated cells. Cleavage of PARP-1, down-regulation of Mcl-1 and activation of caspases correlated well with CDK inhibition and confirmed apoptosis as the primary type of cell death induced in cancer cells treated with the compounds in vitro. A comparison of known purine-based CDK inhibitor CR8 with its pyrazolo[4,3-d]pyrimidine bioisosteres confirmed that the novel compounds are more potent in cellular assays than purines. Therefore, pyrazolo[4,3-d]pyrimidine may emerge as a novel scaffold in medicinal chemistry and as a source of potent CDK inhibitors.
    Permanent Link: http://hdl.handle.net/11104/0259567

     
    FileDownloadSizeCommentaryVersionAccess
    2016_Vymetalova_EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY_291.pdf01.2 MBOtheropen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.